Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Minimal residual disease-based risk stratification in Chinese childhood acute lymphoblastic leukemia by flow cytometry and plasma DNA quantitative polymerase chain reaction.
Cheng SH, Lau KM, Li CK, Chan NP, Ip RK, Cheng CK, Lee V, Shing MM, Leung AW, Ha SY, Cheuk DK, Lee AC, Li CH, Luk CW, Ling SC, Hrusak O, Mejstrikova E, Leung Y, Ng MH. Cheng SH, et al. Among authors: hrusak o. PLoS One. 2013 Jul 25;8(7):e69467. doi: 10.1371/journal.pone.0069467. Print 2013. PLoS One. 2013. PMID: 23936021 Free PMC article.
Childhood secondary ALL after ALL treatment.
Zuna J, Cavé H, Eckert C, Szczepanski T, Meyer C, Mejstrikova E, Fronkova E, Muzikova K, Clappier E, Mendelova D, Boutard P, Schrauder A, Sterba J, Marschalek R, van Dongen JJ, Hrusak O, Stary J, Trka J. Zuna J, et al. Among authors: hrusak o. Leukemia. 2007 Jul;21(7):1431-5. doi: 10.1038/sj.leu.2404718. Epub 2007 Apr 26. Leukemia. 2007. PMID: 17460701
Minimal residual disease (MRD) analysis in the non-MRD-based ALL IC-BFM 2002 protocol for childhood ALL: is it possible to avoid MRD testing?
Fronkova E, Mejstrikova E, Avigad S, Chik KW, Castillo L, Manor S, Reznickova L, Valova T, Zdrahalova K, Hrusak O, Jabali Y, Schrappe M, Conter V, Izraeli S, Li CK, Stark B, Stary J, Trka J. Fronkova E, et al. Among authors: hrusak o. Leukemia. 2008 May;22(5):989-97. doi: 10.1038/leu.2008.22. Epub 2008 Feb 28. Leukemia. 2008. PMID: 18305563 Clinical Trial.
Detection of residual B precursor lymphoblastic leukemia by uniform gating flow cytometry.
Mejstríková E, Fronková E, Kalina T, Omelka M, Batinić D, Dubravcić K, Pospísilová K, Vásková M, Luria D, Cheng SH, Ng M, Leung Y, Kappelmayer J, Kiss F, Izraeli S, Stark B, Schrappe M, Trka J, Starý J, Hrusák O. Mejstríková E, et al. Among authors: hrusak o. Pediatr Blood Cancer. 2010 Jan;54(1):62-70. doi: 10.1002/pbc.22261. Pediatr Blood Cancer. 2010. PMID: 19760767
Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria.
Mejstrikova E, Volejnikova J, Fronkova E, Zdrahalova K, Kalina T, Sterba J, Jabali Y, Mihal V, Blazek B, Cerna Z, Prochazkova D, Hak J, Zemanova Z, Jarosova M, Oltova A, Sedlacek P, Schwarz J, Zuna J, Trka J, Stary J, Hrusak O. Mejstrikova E, et al. Among authors: hrusak o. Haematologica. 2010 Jun;95(6):928-35. doi: 10.3324/haematol.2009.014506. Epub 2010 Feb 9. Haematologica. 2010. PMID: 20145275 Free PMC article.
113 results